303 related articles for article (PubMed ID: 27890459)
1. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
2. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
3. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
[TBL] [Abstract][Full Text] [Related]
4. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
5. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.
Williams AM; Shah R; Shayne M; Huston AJ; Krebs M; Murray N; Thompson BD; Doyle K; Korotkin J; van Wijngaarden E; Hyland S; Moynihan JA; Cory-Slechta DA; Janelsins MC
J Neuroimmunol; 2018 Jan; 314():17-23. PubMed ID: 29128118
[TBL] [Abstract][Full Text] [Related]
6. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
7. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
8. Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer.
Janelsins MC; Lei L; Netherby-Winslow C; Kleckner AS; Kerns S; Gilmore N; Belcher E; Thompson BD; Werner ZA; Hopkins JO; Long J; Cole S; Culakova E
J Neuroimmunol; 2022 Jan; 362():577769. PubMed ID: 34871864
[TBL] [Abstract][Full Text] [Related]
9. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
10. Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors.
Henneghan A; Haley AP; Kesler S
Biol Res Nurs; 2020 Jan; 22(1):126-138. PubMed ID: 31707784
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
12. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
13. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.
Pomykala KL; Ganz PA; Bower JE; Kwan L; Castellon SA; Mallam S; Cheng I; Ahn R; Breen EC; Irwin MR; Silverman DH
Brain Imaging Behav; 2013 Dec; 7(4):511-23. PubMed ID: 23835929
[TBL] [Abstract][Full Text] [Related]
14. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.
Janelsins MC; Mustian KM; Palesh OG; Mohile SG; Peppone LJ; Sprod LK; Heckler CE; Roscoe JA; Katz AW; Williams JP; Morrow GR
Support Care Cancer; 2012 Apr; 20(4):831-9. PubMed ID: 21533812
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
18. Predictors of cognitive decline after chemotherapy in breast cancer patients.
Vearncombe KJ; Rolfe M; Wright M; Pachana NA; Andrew B; Beadle G
J Int Neuropsychol Soc; 2009 Nov; 15(6):951-62. PubMed ID: 19709455
[TBL] [Abstract][Full Text] [Related]
19. Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy.
Belcher EK; Culakova E; Gilmore NJ; Hardy SJ; Kleckner AS; Kleckner IR; Lei L; Heckler C; Sohn MB; Thompson BD; Lotta LT; Werner ZA; Geer J; Hopkins JO; Corso SW; Rich DQ; van Wijngaarden E; Janelsins MC
J Natl Cancer Inst; 2022 May; 114(5):712-721. PubMed ID: 35134984
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.
Meyers CA; Albitar M; Estey E
Cancer; 2005 Aug; 104(4):788-93. PubMed ID: 15973668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
